Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CYPRESS BIOSCIENCE INC (CYPB) Create: Alert

All | News | Filings
Date FiledTypeDescription
12/22/2010 8-K Quarterly results
12/16/2010 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Financial Statements and Ex...
Docs: "Agreement and Plan of Merger, by and among Cypress Bioscience, Inc., Ramius Value and Opportunity Advisors LLC, Royalty Pharma US Partners, LP, Royalty Pharma US Partners 2008, LP, RP Investment Corp. and Ramius V&O Acquisition LLC",
"Amendment No. 1 to Rights Agreement, by and among Cypress Bioscience, Inc. and American Stock Transfer & Trust Company, LLC, as rights agent"
12/15/2010 8-K Form 8-K - Current report
11/09/2010 8-K Form 8-K - Current report
10/08/2010 8-K Form 8-K - Current report
09/28/2010 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Financial Statements and Ex...
Docs: "Form of Certificate of Designation of Series A Junior Participating Preferred Stock",
"Rights Agreement, by and between the Company and American Stock Transfer & Trust Company, LLC",
"Form of Right Certificate"
09/15/2010 8-K Form 8-K - Current report
08/31/2010 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
08/26/2010 8-K Form 8-K - Current report
08/19/2010 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
08/18/2010 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/17/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "CYPRESS BIOSCIENCE SENDS LETTER TO RAMIUS"
08/09/2010 8-K Quarterly results
Docs: "Cypress Bioscience Announces Second Quarter 2010 Financial Results"
08/05/2010 8-K Entry into a Material Definitive Agreement, Cost Associated with Exit or Disposal Activities, Financial Statements and Exhibits
Docs: "CYPRESS BIOSCIENCE ANNOUNCES AGREEMENT TO DISCONTINUE"
07/20/2010 8-K Form 8-K - Current report
07/12/2010 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Company Update"
06/24/2010 8-K Entry into a Material Definitive Agreement
06/15/2010 8-K Form 8-K - Current report
05/10/2010 8-K Quarterly results
Docs: "Cypress Bioscience Announces First Quarter 2010 Financial Results"
04/12/2010 8-K Form 8-K - Current report
03/31/2010 8-K Quarterly results
Docs: "Cypress Bioscience Announces 2009 Financial Results"
11/09/2009 8-K Form 8-K - Current report
08/10/2009 8-K Form 8-K - Current report
06/17/2009 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Cypress Bioscience, Inc. 2009 Equity Incentive Plan"
05/11/2009 8-K Form 8-K -- Current report
05/06/2009 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "Fourth Amended and Restated Bylaws of Cypress Bioscience, Inc"
04/21/2009 8-K Form 8-K -- Current report
04/14/2009 8-K Form 8-K -- Current report
03/16/2009 8-K Quarterly results
Docs: "Cypress Bioscience, Inc. Announces 2008 Financial Results"
03/09/2009 8-K Form 8-K -- Current report
01/20/2009 8-K Form 8-K -- Current report
01/15/2009 8-K Form 8-K -- Current report
12/08/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "FOREST LABORATORIES, INC. AND CYPRESS BIOSCIENCE, INC. ANNOUNCE POSITIVE RESULTS OF PHASE III STUDY OF MILNACIPRAN FOR THE MANAGEMENT OF FIBROMYALGIA"
11/10/2008 8-K Quarterly results
Docs: "Cypress Bioscience, Inc. Announces Third Quarter 2008 Results"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy